Welcome to LookChem.com Sign In|Join Free

CAS

  • or

604813-07-2

Post Buying Request

604813-07-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

604813-07-2 Usage

General Description

N-ETHYL-4-CHLORO-PYRIDINE-2-CARBOXAMIDE is a chemical compound with the molecular formula C9H10ClN3O. It is a pyridine derivative with a chloro group and an ethyl substituent attached to the nitrogen atom, as well as a carboxamide group in the 2-position of the pyridine ring. N-ETHYL-4-CHLORO-PYRIDINE-2-CARBOXAMIDE is primarily used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It has also been found to exhibit certain biological activities, such as antifungal and antibacterial properties, making it a potential candidate for drug development. Additionally, it may have other industrial applications, such as in the production of dyes or pigments. However, due to its potential toxicological and environmental effects, careful handling and disposal of N-ETHYL-4-CHLORO-PYRIDINE-2-CARBOXAMIDE are necessary to minimize any negative impacts.

Check Digit Verification of cas no

The CAS Registry Mumber 604813-07-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,4,8,1 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 604813-07:
(8*6)+(7*0)+(6*4)+(5*8)+(4*1)+(3*3)+(2*0)+(1*7)=132
132 % 10 = 2
So 604813-07-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H9ClN2O/c1-2-10-8(12)7-5-6(9)3-4-11-7/h3-5H,2H2,1H3,(H,10,12)

604813-07-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-chloro-N-ethylpyridine-2-carboxamide

1.2 Other means of identification

Product number -
Other names N-Ethyl 4-chloropicolinamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:604813-07-2 SDS

604813-07-2Downstream Products

604813-07-2Relevant articles and documents

Discovery of novel 2-substituted-4-phenoxypyridine derivatives as potential antitumor agents

Duan, Yongli,Xu, Shan,Xiong, Hehua,Wang, Linxiao,Zhao, Bingbing,Wang, Ping,Wang, Caolin,Peng, Yiqing,Cai, Shifan,Luo, Rong,Zheng, Pengwu,Tang, Qidong

, p. 254 - 259 (2018/01/10)

A series of 2-substituted-4-phenoxypyridine derivatives were designed, synthesized, and evaluated for their antiproliferative activity against 4 cancer cell lines (A549, HT-29, H460, and U87MG) in vitro. Most compounds showed moderate to excellent potency. Nine tyrosine kinases (c-Met, Flt-3, ALK, VEGFR-2, VEGFR-3, PDGFR-α PDGFR-β c-Kit, and EGFR) were used to evaluate the inhibitory activities with the most promising analogue 39, which showed the Flt-3/c-Met IC50 values of 2.18/2.61 nM. Structure-activity relationship studies indicated that n-Pr served as R1 group showed a higher preference, and stronger mono-EWGs on the phenyl ring (such as R2 = 4-F) was benefited to the potency.

Design, synthesis and biological activities of sorafenib derivatives as antitumor agents

Yao, Jianwen,He, Zuopeng,Chen, Jing,Sun, Wei,Fang, Hao,Xu, Wenfang

, p. 6549 - 6553,5 (2012/12/12)

A series of novel sorafenib derivatives, 9a-w, was designed and synthesized in high yields using various substituted anilines, and their antiproliferative activities against HCT116, PC-3 and MDA-MB-231 cell lines were also evaluated and described. All compounds exhibited potent antiproliferative activity against HCT116 and PC-3 cells with IC50 = 2.8-52.0 and 2.2-45.6 μM; compounds 9p and 9q demonstrated competitive antiproliferative activities to sorafenib against all three cancer cell lines, the cytotoxicity of compound 9r is more potent than that of sorafenib. Compounds (9g, 9p, 9q and 9r) were chosen for further evaluation of the anti-angiogenesis activity, and showed the inhibition of sprout formation from aortic ring ex vivo. The structures of all the newly synthesized compounds were determined by 1H NMR, 13C NMR and HRMS.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 604813-07-2